Ketone Hydrogenation with Iridium Complexes with “non N–H” Ligands: The Key Role of the Strong Base

Ferrocenyl phosphine thioether ligands (PS), not containing deprotonatable functions, efficiently support the iridium catalyzed ketone hydrogenation in combination with a strong base co-catalyst. Use of an internal base ([Ir(OMe)(COD)]2 in place of [IrCl(COD)]2) is not sufficient to insure activity and a strong base is still necessary, suggesting that the active catalyst is an anionic hydride complex. Computational investigations that include solvent effects demonstrate the thermodynamically accessible generation of the tetrahydrido complex [IrH4(PS)]-and suggest an operating cycle via a [Na+(MeOH)3∙∙∙Ir-H4(PS)] contact ion pair with an energy span of 18.2 kcal/mol. The cycle involves an outer sphere stepwise H-/H+ transfer, the proton originating from H2 after coordination and heterolytic activation. The base plays the dual role of generating the anionic complex and providing the Lewis acid co-catalyst for ketone activation. The best cycle for the neutral system, on the other hand, requires an energy span of 26.3 kcal/mol. This work highlights, for the first time, the possibility of outer sphere hydrogenation in the presence of non deprotonatable ligands and the role of the strong base in the activation of catalytic systems with such type of ligands

Structure and dynamics of [Nb(η5-C5H4SiMe3) 2(η2-H2BR2)] (R2 = O2C6H4, C8H14, H2) complexes. A combined experimental and theoretical study

Dihydrogen elimination from the reaction of the niobocene trihydride Cp‘2NbH3 (Cp‘ = η5-C5H4SiMe3) and the appropriate borane provides a synthetic route to the new borate-containing niobocene complexes [Nb(η5-C5H4SiMe3)2(η2-H2BR2)] (R2 = O2C6H4 (1), C8H14 (2), H2 (3)). The reaction with H2BO2C6H4 or H2BC8H14 proceeds at mild temperature, and the BH3·THF adduct reacts even at low temperature. Complexes 2 and 3 show dynamic behavior in solution. Spectroscopic and theoretical studies were carried out in order to clarify these dynamic processes. In addition, X-ray diffraction studies of 2 were carried out and the results correlated with the theoretical data. Finally, reactions of Cp‘2Nb(H)(L) (L = CO, CN(2,6-Me2C6H3), tBuOOCHCHCOOtBu) with BH3·THF give rise to the complex 3, with the elimination of the appropriate ancillary ligand L.Financial support from the Spanish Comisión Interministerial de Ciencia y Tecnología (Projects PB98-0915, PB98-0916-CO2-01, and PB-95-0023-CO1-CO2) is acknowledged.Peer reviewe

Homochiral Metal-Organic Frameworks for Enantioselective Separations in Liquid Chromatography

Selective separation of enantiomers is a substantial challenge for the pharmaceutical industry. Chromatography on chiral stationary phases is the standard method, but at a very high cost for industrial-scale purification owing to the high cost of the chiral stationary phases. Typically, these materials are poorly robust, expensive to manufacture and often too specific for a single desired substrate, lacking desirable versatility across different chiral analytes. Here we disclose a porous, robust homochiral metal-organic framework (MOF), TAMOF-1, built from copper(II) and an affordable linker prepared from natural L-histidine. TAMOF-1 has shown to be able to separate a variety of model racemic mixtures, including drugs, in a wide range of solvents of different polarity, outperforming several commercial chiral columns for HPLC separations. Although not exploited in the present article, it is worthy to mention that the preparation of this new material is scalable to the multikilogram scale, opening unprecedented possibilities for low-energy chiral separation at the industrial scale

Altered methylation pattern in EXOC4 is associated with stroke outcome: an epigenome-wide association study

Background and purpose: The neurological course after stroke is highly variable and is determined by demographic, clinical and genetic factors. However, other heritable factors such as epigenetic DNA methylation could play a role in neurological changes after stroke. Methods: We performed a three-stage epigenome-wide association study to evaluate DNA methylation associated with the difference between the National Institutes of Health Stroke Scale (NIHSS) at baseline and at discharge (Delta NIHSS) in ischaemic stroke patients. DNA methylation data in the Discovery (n = 643) and Replication (n = 62) Cohorts were interrogated with the 450 K and EPIC BeadChip. Nominal CpG sites from the Discovery (p value < 10(-06)) were also evaluated in a meta-analysis of the Discovery and Replication cohorts, using a random-fixed effect model. Metabolic pathway enrichment was calculated with methylGSA. We integrated the methylation data with 1305 plasma protein expression levels measured by SOMAscan in 46 subjects and measured RNA expression with RT-PCR in a subgroup of 13 subjects. Specific cell-type methylation was assessed using EpiDISH. Results: The meta-analysis revealed an epigenome-wide significant association in EXOC4 (p value = 8.4 x 10(-08)) and in MERTK (p value = 1.56 x 10(-07)). Only the methylation in EXOC4 was also associated in the Discovery and in the Replication Cohorts (p value = 1.14 x 10(-06) and p value = 1.3 x 10(-02), respectively). EXOC4 methylation negatively correlated with the long-term outcome (coefficient = - 4.91) and showed a tendency towards a decrease in EXOC4 expression (rho = - 0.469, p value = 0.091). Pathway enrichment from the meta-analysis revealed significant associations related to the endocytosis and deubiquitination processes. Seventy-nine plasma proteins were differentially expressed in association with EXOC4 methylation. Pathway analysis of these proteins showed an enrichment in natural killer (NK) cell activation. The cell-type methylation analysis in blood also revealed a differential methylation in NK cells. Conclusions: DNA methylation of EXOC4 is associated with a worse neurological course after stroke. The results indicate a potential modulation of pathways involving endocytosis and NK cells regulation

Oxidative addition of group 14 element hydrido compounds to OsH2(h2-CH2=CHEt)(CO)(PiPr3)2: Synthesis and characterization of the first trihydrido-silyl, trihydrido-germyl and trihydrido-stannyl derivatives of Os(IV)

The dihydrido−olefin complex OsH2(η2-CH2CHEt)(CO)(PiPr3)2 (2) reacts with H2SiPh2 to give OsH3(SiHPh2)(CO)(PiPr3)2 (3). The molecular structure of 3 has been determined by X-ray diffraction (monoclinic, space group P21/c with a = 16.375(2) Å, b = 11.670(1) Å, c =18.806(2) Å, β = 107.67(1)°, and Z = 4) together with ab initio calculations on the model compound OsH3(SiH3)(CO)(PH3)2. The coordination geometry around the osmium center can be rationalized as a heavily distorted pentagonal bipyramid with one hydrido ligand and the carbonyl group in the axial positions. The two other hydrido ligands lie in the equatorial plane, one between the phosphine ligands and the other between the SiHPh2 group and one of the phosphine ligands. Complex 3 can also be prepared by reaction of OsH(η2-H2BH2)(CO)(PiPr3)2 (4) with H2SiPh2. Similarly, the treatment of 4 with HSiPh3 affords OsH3(SiPh3)(CO)(PiPr3)2 (5), while the addition of H3SiPh to 4 in methanol yields OsH3{Si(OMe)2Ph}(CO)(PiPr3)2 (6). Complex 2 also reacts with HGeR3 and HSnR3 to give OsH3(GeR3)(CO)(PiPr3)2 (GeR3 = GeHPh2 (7), GePh3 (8), GeEt3 (9)) and OsH3(SnR3)(CO)(PiPr3)2 (R = Ph (10), nBu (11)), respectively. In solution, compounds 3 and 5−11 are fluxional and display similar 1H and 31P{1H} NMR spectra, suggesting that they possess a similar arrangement of ligands around the osmium atom.We thank the DGICYT (Projects PB92-0092, PB92-0621, and PB93-0222, Programa de Promoción General del Conocimiento) and the EU (Project:  Selective Processes and Catalysis involving Small Molecules) for financial support. E.O. thanks the DGA (Diputación General de Aragón) for a grant.Peer reviewe

Counteranion-Dependent Reaction Pathways in the Protonation of Cationic Ruthenium−Vinylidene Complexes

The tetraphenylborate salts of the cationic vinylidene complexes [Cp*Ru=C=CHR(iPr2PNHPy)]+ (R = p-C6H4CF3 (1a-BPh4), Ph (1b-BPh4), p-C6H4CH3 (1c- BPh4), p-C6H4Br (1d-BPh4), tBu (1e-BPh4), H (1f-BPh4)) have been protonated using an excess of HBF4·OEt2 in CD2Cl2, furnishing the dicationic carbyne complexes [Cp*Ru≡CCH2R(iPr2PNHPy)]2+ (R = p-C6H4CF3 (2a), Ph (2b), p-C6H4CH3 (2c), p-C6H4Br (2d), tBu (2e), H (2f)), which were characterized in solution at low temperature by NMR spectroscopy. The corresponding reaction of the chloride salts 1a-Cl, 1b-Cl, 1c-Cl, and 1d-Cl followed a different pathway, instead affording the novel alkene complexes [Cp*RuCl(κ1(N),η2(C,C)-C5H4N-NHPiPr2CH=CHR)][BF4] (3a−d). In these species, the entering proton is located at the α- carbon atom of the former vinylidene ligand, which also forms a P−C bond with the phosphorus atom of the iPr2PNHPy ligand. To shed light on the reaction mechanism, DFT calculations have been performed by considering several protonation sites. The computational results suggest metal protonation followed by insertion. The coordination of chloride to ruthenium leads to alkenyl species which can undergo a P−C coupling to yield the corresponding alkene complexes. The noncoordinating nature of [BPh4]− does not allow the stabilization of the unsaturated species coming from the insertion step, thus preventing this alternative pathway

Counteranion and Solvent Assistance in Ruthenium-Mediated Alkyne to Vinylidene Isomerizations

The complex [Cp*RuCl(iPr2PNHPy)] (1) reacts with 1-alkynes HC≡CR (R = COOMe, C6H4CF3) in dichloromethane furnishing the corresponding vinylidene complexes [Cp*Ru≡C≡CHR(iPr2PNHPy)]Cl (R = COOMe (2a- Cl), C6H4CF3 (2b-Cl)), whereas reaction of 1 with NaBPh4 in MeOH followed by addition of HC≡CR (R = COOMe, C6H4CF3) yields the metastable π-alkyne complexes [Cp*Ru(η2-HC≡CR)(iPr2PNHPy)][BPh4] (R = COOMe (3a-BPh4), C6H4CF3 (3b-BPh4)). The transformation of 3a-BPh4/3b-BPh4 into their respective vinylidene isomers in dichloromethane is very slow and requires hours to its completion. However, this process is accelerated by addition of LiCl in methanol solution. Reaction of 1 with HC≡CR (R = COOMe, C6H4CF3) in MeOH goes through the intermediacy of the π-alkyne complexes [Cp*Ru(η2-HC≡CR)(iPr2PNHPy)]Cl (R = COOMe (3a-Cl), C6H4CF3 (3b-Cl)), which rearrange to vinylidenes in minutes, i.e., much faster than their counterparts containing the [BPh4]− anion. The kinetics of these isomerizations has been studied in solution by NMR. With the help of DFT studies, these observations have been interpreted in terms of chloride- and methanolassisted hydrogen migrations. Calculations suggest participation of a hydrido−alkynyl intermediate in the process, in which the hydrogen atom can be transferred from the metal to the β-carbon by means of species with weak basic character acting as proton shuttles

Table_3_A Polygenic Risk Score Based on a Cardioembolic Stroke Multitrait Analysis Improves a Clinical Prediction Model for This Stroke Subtype.DOCX

[Background] Occult atrial fibrillation (AF) is one of the major causes of embolic stroke of undetermined source (ESUS). Knowing the underlying etiology of an ESUS will reduce stroke recurrence and/or unnecessary use of anticoagulants. Understanding cardioembolic strokes (CES), whose main cause is AF, will provide tools to select patients who would benefit from anticoagulants among those with ESUS or AF. We aimed to discover novel loci associated with CES and create a polygenetic risk score (PRS) for a more efficient CES risk stratification.[Methods] Multitrait analysis of GWAS (MTAG) was performed with MEGASTROKE-CES cohort (n = 362,661) and AF cohort (n = 1,030,836). We considered significant variants and replicated those variants with MTAG p-value < 5 × 10−8 influencing both traits (GWAS-pairwise) with a p-value < 0.05 in the original GWAS and in an independent cohort (n = 9,105). The PRS was created with PRSice-2 and evaluated in the independent cohort.[Results] We found and replicated eleven loci associated with CES. Eight were novel loci. Seven of them had been previously associated with AF, namely, CAV1, ESR2, GORAB, IGF1R, NEURL1, WIPF1, and ZEB2. KIAA1755 locus had never been associated with CES/AF, leading its index variant to a missense change (R1045W). The PRS generated has been significantly associated with CES improving discrimination and patient reclassification of a model with age, sex, and hypertension.[Conclusion] The loci found significantly associated with CES in the MTAG, together with the creation of a PRS that improves the predictive clinical models of CES, might help guide future clinical trials of anticoagulant therapy in patients with ESUS or AF.Peer reviewe